Duke University [clinicaltrials_resource:47d3190e77e5a3a53558812f597b0b92]
Mary Horowitz, MD, MS [clinicaltrials_resource:00114a82830f577a9787a292e5cd0661]Angeles A Secord, MD [clinicaltrials_resource:010a79d04c5b7f90e22e4b90fbba9828]Melissa Watt, PhD [clinicaltrials_resource:0126c23620cc1ead3ddc666754d31d18]Jean C. Beckham, Ph.D. [clinicaltrials_resource:01711e6d4e0c88f920b4e961a6e8e446]Elizabeth B Malinzak, MD [clinicaltrials_resource:01ab3ad5d5fce9ff7b8bbd02e2cda394]Jennifer R Benjamin, MD [clinicaltrials_resource:01af24763845dc301cac20bd8327206a]Cristina Hendrix, DNS [clinicaltrials_resource:01d46df7c01c4b6728bbf73f6ceba748]Courtney D Thornburg, MD, MS [clinicaltrials_resource:01d971e772ed75a43672e76d21410454]David B MacLeod, MD [clinicaltrials_resource:02384e3704be0524d48ec32dabde3205]Dwight D Koeberl, MD, PhD [clinicaltrials_resource:02b7b4cb50ce409a662de65f93844c19]Robin M Queen, PhD [clinicaltrials_resource:0321350f8f2b7e59664c4f7c8a33b763]Ranee C Montgomery, MD [clinicaltrials_resource:033c08784b93710af175ee62a650a9b3]DaiWai M Olson, Phd RN CCRN [clinicaltrials_resource:035cbe6b3f0676414651ee2260f13c00]Huiman X. Barnhart, PhD [clinicaltrials_resource:038339aad3afd7fb6cabf32551ce7933]Philip Omotosho, MD [clinicaltrials_resource:039c206458521fa122798d0ef38451cb]Anthony Sung, MD [clinicaltrials_resource:03a2c54e71ea71955f27cf8835ae3bd1]Stephen J Freedland, MD [clinicaltrials_resource:03d648f5e602ae972cf8d2bdfeb676a6]William Kraus, MD [clinicaltrials_resource:03ead07be3e1c2de30e50f62895657b8]Priya Kishnani, MD [clinicaltrials_resource:03f352b52504677541556cf48c6bb1c7]Gary Bennett, PhD [clinicaltrials_resource:04309825bede6b84a887ae5ac5322e5d]Brant Inman, MD [clinicaltrials_resource:04684482dd07f7ce6ffe3e59581d90ea]Joanne Kurtzberg, MD [clinicaltrials_resource:04abf4eda9cd97e5526bfcd5d9600996]Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Kathryn Pollak, PhD [clinicaltrials_resource:0552eb30312bad29fb062b69935086ec]Adrian Hernandez, MD,MHS,FAHA [clinicaltrials_resource:05b0ef229dc7ffbe58e3b169b151099d]Judith M. Kramer, MD,MS [clinicaltrials_resource:05d484170a330374209c070a028db9e8]Susannah D Copland, MD [clinicaltrials_resource:05f11bf058aa1d01266dbc4255bffcbd]Wei Zhang, MD [clinicaltrials_resource:05f90945a83f393298ef2acd3ec9f24a]Helen Hoenig, MD [clinicaltrials_resource:062298e8d74080f5e5e99c58c32f2c19]Truls Ostbye, MD PhD [clinicaltrials_resource:0630f5cc631c2df2ff9e4f9c41b4e037]Jeffrey Lawson, MD [clinicaltrials_resource:063fc0103f96e039da29696a87957459]Sascha Tuchman, MD [clinicaltrials_resource:064dac24fdcb9551e7ea8686dd628e86]Kishore Gadde, MD [clinicaltrials_resource:064f21a16f11e92c546738ad51c5d91f]Melissa Watt, PhD [clinicaltrials_resource:0652c19ae34d849217b4f0a7577560d1]Robert M Califf, MD [clinicaltrials_resource:068f5946643cd29b8b7cab6a6ef1e3c5]Alexey G Mukhin, M.D., Ph.D. [clinicaltrials_resource:06d8ef17ba5f14a0c40614cda8f5b463]Robert Noveck, MD, PhD [clinicaltrials_resource:06ef7adcac1521bd4f87cde84db17c40]John L Beyer, M.D [clinicaltrials_resource:07605566490b5b688f5968f8e91cb742]Terri G Monk, MD [clinicaltrials_resource:076623669182d3e597e41b4ca6c0f009]Michael Bolognesi, MD [clinicaltrials_resource:078ee67fec6891077a2952680b5811ce]
affiliation [clinicaltrials_vocabulary:affiliation]
Behavioral Insomnia Therapy for Fibromyalgia [clinicaltrials:NCT00000397]Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [clinicaltrials:NCT00002754]Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00002988]LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases [clinicaltrials:NCT00003020]Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal [clinicaltrials:NCT00003229]Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain [clinicaltrials:NCT00003348]Flt3L in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00003431]clinicaltrials:NCT00003432Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer [clinicaltrials:NCT00003434]Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors [clinicaltrials:NCT00003461]Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors [clinicaltrials:NCT00003462]Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [clinicaltrials:NCT00003463]Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme [clinicaltrials:NCT00003464]Temozolomide in Treating Patients With Anaplastic Oligodendroglioma [clinicaltrials:NCT00003465]Temozolomide in Treating Patients With Progressive Low-Grade Glioma [clinicaltrials:NCT00003466]Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma [clinicaltrials:NCT00003467]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors [clinicaltrials:NCT00003478]Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00004211]clinicaltrials:NCT00004604Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma [clinicaltrials:NCT00005081]Behavioral Factors in Coronary Heart Disease [clinicaltrials:NCT00005314]University of North Carolina Alumni Heart Study [clinicaltrials:NCT00005398]Hostility, Depression, Social Environment and CHD Risk [clinicaltrials:NCT00005533]Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer [clinicaltrials:NCT00005816]Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00005951]clinicaltrials:NCT00005952Temozolomide in Treating Patients With Brain Metastases [clinicaltrials:NCT00005954]Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors [clinicaltrials:NCT00005955]Biological Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00005956]Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor [clinicaltrials:NCT00006342]Hypertension in Black Americans: A Life Course Approach [clinicaltrials:NCT00006408]Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma [clinicaltrials:NCT00006474]Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00010127]ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse [clinicaltrials:NCT00016991]clinicaltrials:NCT00023595Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer [clinicaltrials:NCT00037024]EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [clinicaltrials:NCT00041028]clinicaltrials:NCT00041392Combined Behavioral/Pharmacological Therapy for Insomnia [clinicaltrials:NCT00044629]
collaborator [clinicaltrials_vocabulary:collaborator]
Behavioral Insomnia Therapy for Fibromyalgia [clinicaltrials:NCT00000397]Carboplatin in Patients With Progressive Gliomas [clinicaltrials:NCT00002749]Melphalan in Patients With Neoplastic Meningitis [clinicaltrials:NCT00002750]Monoclonal Antibody Therapy in Treating Patients With Brain Metastases [clinicaltrials:NCT00002751]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers [clinicaltrials:NCT00002752]Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas [clinicaltrials:NCT00002753]Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [clinicaltrials:NCT00002754]Chemotherapy in Treating Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00002986]Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00002988]LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases [clinicaltrials:NCT00003020]Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal [clinicaltrials:NCT00003229]Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain [clinicaltrials:NCT00003348]Flt3L in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00003431]clinicaltrials:NCT00003432Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer [clinicaltrials:NCT00003434]Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors [clinicaltrials:NCT00003461]Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors [clinicaltrials:NCT00003462]Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [clinicaltrials:NCT00003463]Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme [clinicaltrials:NCT00003464]Temozolomide in Treating Patients With Anaplastic Oligodendroglioma [clinicaltrials:NCT00003465]Temozolomide in Treating Patients With Progressive Low-Grade Glioma [clinicaltrials:NCT00003466]Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma [clinicaltrials:NCT00003467]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors [clinicaltrials:NCT00003478]Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00004211]clinicaltrials:NCT00004604Study of Axial Mobility Exercises in Parkinson Disease [clinicaltrials:NCT00004760]Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma [clinicaltrials:NCT00005081]Behavioral Factors in Coronary Heart Disease [clinicaltrials:NCT00005314]University of North Carolina Alumni Heart Study [clinicaltrials:NCT00005398]Hostility, Depression, Social Environment and CHD Risk [clinicaltrials:NCT00005533]Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer [clinicaltrials:NCT00005816]Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00005951]clinicaltrials:NCT00005952Temozolomide in Treating Patients With Brain Metastases [clinicaltrials:NCT00005954]Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors [clinicaltrials:NCT00005955]Biological Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00005956]Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor [clinicaltrials:NCT00006342]Hypertension in Black Americans: A Life Course Approach [clinicaltrials:NCT00006408]Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma [clinicaltrials:NCT00006474]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Heather Shaw, MD, Duke University [clinicaltrials_resource:3ad45271da99f756e557cd5c647bbbee]Robert Hubbard, Ph.D., Duke University [clinicaltrials_resource:412e9b2310f45ed40d035c5910c1f5a9]Paolo Mannelli, M.D., Duke University [clinicaltrials_resource:92d1e7fe574b903d2f5ccbc8314850a1]George D. Webster, MD, Duke University [clinicaltrials_resource:aa0be7c29f43f70a313d062af53db8ca]
organization [clinicaltrials_vocabulary:organization]
Behavioral Insomnia Therapy for Fibromyalgia [clinicaltrials:NCT00000397]Carboplatin in Patients With Progressive Gliomas [clinicaltrials:NCT00002749]Melphalan in Patients With Neoplastic Meningitis [clinicaltrials:NCT00002750]Monoclonal Antibody Therapy in Treating Patients With Brain Metastases [clinicaltrials:NCT00002751]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers [clinicaltrials:NCT00002752]Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas [clinicaltrials:NCT00002753]Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [clinicaltrials:NCT00002754]Chemotherapy in Treating Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00002986]Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00002988]LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases [clinicaltrials:NCT00003020]Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal [clinicaltrials:NCT00003229]Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain [clinicaltrials:NCT00003348]Flt3L in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00003431]clinicaltrials:NCT00003432Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer [clinicaltrials:NCT00003434]Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors [clinicaltrials:NCT00003461]Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors [clinicaltrials:NCT00003462]Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [clinicaltrials:NCT00003463]Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme [clinicaltrials:NCT00003464]Temozolomide in Treating Patients With Anaplastic Oligodendroglioma [clinicaltrials:NCT00003465]Temozolomide in Treating Patients With Progressive Low-Grade Glioma [clinicaltrials:NCT00003466]Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma [clinicaltrials:NCT00003467]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors [clinicaltrials:NCT00003478]Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors [clinicaltrials:NCT00003484]clinicaltrials:NCT00004143Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00004211]clinicaltrials:NCT00004604Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma [clinicaltrials:NCT00005081]Behavioral Factors in Coronary Heart Disease [clinicaltrials:NCT00005314]University of North Carolina Alumni Heart Study [clinicaltrials:NCT00005398]Hostility, Depression, Social Environment and CHD Risk [clinicaltrials:NCT00005533]Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer [clinicaltrials:NCT00005816]Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00005951]clinicaltrials:NCT00005952Temozolomide in Treating Patients With Brain Metastases [clinicaltrials:NCT00005954]Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors [clinicaltrials:NCT00005955]Biological Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00005956]Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor [clinicaltrials:NCT00006342]Hypertension in Black Americans: A Life Course Approach [clinicaltrials:NCT00006408]
source [clinicaltrials_vocabulary:source]
Duke University [clinicaltrials_resource:47d3190e77e5a3a53558812f597b0b92]
Bio2RDF identifier
47d3190e77e5a3a53558812f597b0b92
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:47d3190e77e5a3a53558812f597b0b92
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:47d3190e77e5a3a53558812f597b0b92
title
Duke University
@en
type
label
Duke University [clinicaltrials_resource:47d3190e77e5a3a53558812f597b0b92]
@en